Gould Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Gould Capital's MRK Position: Q3 2026 in Review
Gould Capital reduced its Merck (MRK) stake by 1.9% in Q3 2026, selling an estimated $77K and leaving 28,708 shares worth $4.17M. The position accounts for 2.35% of the portfolio, ranked #10.
Gould Capital first reported a position in MRK in Q4 2021 and has held it in 20 quarters since. 3,958 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Gould Capital held 28,708 shares of Merck worth $4.17M as of Q3 2026.
- Gould Capital sold 557 Merck shares in Q3 2026, an estimated $77K.
- Merck made up 2.35% of Gould Capital's portfolio in Q3 2026, its #10 holding.
- Gould Capital first reported a position in Merck in Q4 2021 and has held it in 20 quarters since.
- 3,958 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Gould Capital's 13F filing for Q3 2026, filed 13 Nov 2026.